Y-mAbs
Industry
Drug development oncology
Website
HBM contact
Company status
Public
YmAbs is a clinical stage biotechnology company specialized in developing novel antibody therapeutics to treat cancer. Several ongoing late-stage clinical trials significantly improve survival rates for critical unmet medical needs among cancer patients including pediatric patients.
